- Home
- RLX vs PBH Comparison
RLX vs PBH Comparison
Compare RLX & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLX | PBH |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | RLX | PBH |
|---|---|---|
| Price | $2.35 | $59.77 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $2.25 | ★ $86.40 |
| AVG Volume (30 Days) | ★ 2.1M | 449.1K |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | ★ 4.56% | N/A |
| EPS Growth | ★ 19.33 | N/A |
| EPS | 0.08 | ★ 4.04 |
| Revenue | $459,694,770.00 | ★ $1,110,479,000.00 |
| Revenue This Year | $63.02 | N/A |
| Revenue Next Year | $24.72 | $2.50 |
| P/E Ratio | $29.42 | ★ $14.92 |
| Revenue Growth | ★ 51.58 | N/A |
| 52 Week Low | $1.66 | $57.25 |
| 52 Week High | $2.84 | $90.04 |
Technical Indicators
Market Signals| Indicator | RLX | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 43.65 | 47.26 |
| Support Level | $2.42 | $59.19 |
| Resistance Level | $2.47 | $61.69 |
| Average True Range (ATR) | 0.07 | 1.55 |
| MACD | -0.01 | 0.24 |
| Stochastic Oscillator | 6.12 | 57.41 |
Price Performance
Historical ComparisonAbout RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.